Overview
Status
Active
Registry date
2015-12-16
Share capital
5,000.00 PLN
Registered address
ul. Jana Matejki 19, 43-600 Jaworzno, Poland
Electronic delivery address
AE:PL-11888-97561-WSAWI-19
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
Financial statements were filed on time, on average 13 days early.
- 202513/07/2026
- 202415/07/2025
- 202318/06/2024
- 202216/06/2023
- 202112/07/2022
- 202030/09/2021
Filed on timeDelayFiling deadline
The statements for 2019–2020 report only zeros (no activity).
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Bartłomiej Gendera – President of the Management Board
Tomas Onderek – Vice President of the Management Board
Manner of representation
In the case of a one-person management board, the company is represented by the President of the Management Board independently. In the case of a multi-member management board, the company is represented by each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 14, 2021 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,294$1,294 | Prezydent Miasta Jaworzno |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| EIT Rawmaterials Clc Eastsp. z o.o. | $1,795,803.10 | eitrawmaterials.eu | ||
| RDLSsp. z o.o. | $1,680,515.32 | rdls.pl | ||
| Centrum Innowacji i Wdrożeń Bio-Inwestsp. z o.o. | $1,262,872.91 | bio-inwest.pl | ||
| Bactremsp. z o.o. | $181,958.36 | bactrem.pl | ||
| Biodecsp. z o.o. | $115,508.63 | biodec.pl | ||
| Biostat Research And Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| 4cell TherapiesS.A. | $9,123.06 | 4celltherapies.com | ||
| Medical Algorithmssp. z o.o. | $682.08 | medicalalgorithms.eu | ||
| Codagenesp. z o.o. | – | codagene.com | ||
| Nawah Scientific Polandsp. z o.o. | – | nawah-scientific.com |
Change history
| Date | Event | |
|---|---|---|
| 2019-10-01 | Business resumed | |
| 2017-10-01 | Business suspended | |
| 2015-12-16 | Entered in the register |
FAQ
The main business activity of Subio focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on December 16, 2015.
The headquarters is located at: ul. Jana Matejki 19, 43-600 Jaworzno.
The management board includes Bartłomiej Gendera (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-10-07